Table 2.
High-validity pancreatic cancer quality indicators*
| No. | Quality indicator | Median ranking | Level of measurement | Domain |
| 1 | IF an institution performs pancreatic cancer surgery, THEN the institution should monitor their average annual case volume | 8.5 | Hospital | Structure |
| 2 | IF an institution performs pancreatic cancer surgery, THEN the institution should monitor their surgeons' annual case volume | 8.5 | Hospital | Structure |
| 3 | IF a patient undergoes resection for pancreatic cancer, THEN the patient should be treated in a multidisciplinary effort with a surgeon, medical oncologist, and a radiation oncologist | 8 | Hospital | Structure |
| 4 | IF a patient undergoes resection, THEN the hospital must ensure that the surgeon is certified by the American Board of Surgery or equivalent international organization | 9 | Hospital | Structure |
| 5 | IF an institution performs pancreatic cancer surgery, THEN the hospital should have interventional radiology services available on site | 9 | Hospital | Structure |
| 6 | IF an institution performs pancreatic cancer surgery, THEN the hospital should have an intensive care unit staffed by critical care specialists | 8 | Hospital | Structure |
| 7 | IF a patient undergoes resection, THEN a history and physical with thorough preoperative risk assessment should be performed | 9 | Patient | Process |
| 8 | IF a patient is diagnosed with pancreatic cancer, THEN a stage-specific treatment plan should be documented | 9 | Patient | Process |
| 9 | IF a patient is being considered for resection, THEN a triple-phase, multi-slice CT or MRI scan should be obtained | 9 | Patient | Process |
| 10 | IF a patient undergoes cancer-directed resection, THEN clinical and pathologic stage should be recorded | 9 | Patient | Process |
| 11 | IF a patient undergoes cancer-directed resection, THEN the tumor histology should be recorded | 9 | Patient | Process |
| 12 | IF a patient undergoes cancer-directed resection, THEN the tumor size should be recorded | 9 | Patient | Process |
| 13 | IF a patient undergoes cancer-directed resection, THEN the tumor grade should be recorded | 9 | Patient | Process |
| 14 | IF a patient undergoes cancer-directed resection, THEN the margin status should be recorded | 9 | Patient | Process |
| 15 | IF a patient undergoes cancer-directed resection, THEN the number of lymph nodes examined should be recorded | 9 | Patient | Process |
| 16 | IF a patient undergoes cancer-directed resection, THEN the number of lymph nodes positive should be recorded | 9 | Patient | Process |
| 17 | IF patient undergoes resection of a pancreatic head lesion, THEN in the operative note, the surgeon should document complete removal of all pancreatic tissue, lymph nodes, and connective tissue between the edge of the uncinate process and the right lateral wall of the superior mesenteric artery | 8 | Patient | Process |
| 18 | IF a patient undergoes resection, THEN suspicious adenopathy outside the scope of planned resection should be evaluated by frozen section | 8 | Patient | Process |
| 19 | IF a patient undergoes adjuvant therapy, THEN the timing relative to resection (before, after, both) should be recorded | 8 | Patient | Process |
| 20 | IF a patient undergoes resection, THEN the College of American Pathologists checklist or equivalent reporting system should be followed and fully documented | 8.5 | Patient | Process |
| 21 | IF a patient does not undergo resection, THEN a TNM clinical stage should be recorded | 8 | Patient | Process |
| 22 | IF a patient has clinical stage I or II disease, THEN the patient should undergo resection or have a valid reason documented for not undergoing resection | 9 | Patient | Appropriateness |
| 23 | IF a patient undergoes cancer-directed resection, THEN adjuvant chemotherapy with or without radiation should be considered or administered, or a valid reason should be documented for not receiving adjuvant therapy | 9 | Patient | Appropriateness |
| 24 | IF a patient has clinical stage IV disease, THEN cancer-directed surgery should not be done | 9 | Patient | Appropriateness |
| 25 | IF a patient does not undergo resection, THEN chemotherapy or chemoradiation should be considered or administered or a valid reason should be documented for not receiving non-surgical therapy | 8 | Patient | Appropriateness |
| 26 | IF a patient is to receive treatment, THEN the time from diagnosis to surgery or first treatment should be less than 2 months | 8 | Patient | Efficiency |
| 27 | IF an institution performs pancreatic cancer surgery, THEN the institution should monitor their margin-negative resection rate. | 8 | Hospital | Outcome |
| 28 | IF an institution performs pancreatic cancer surgery, THEN the hospital should monitor their pancreatic cancer resection risk-adjusted perioperative mortality | 8 | Hospital | Outcome |
| 29 | IF an institution performs pancreatic cancer surgery, THEN the hospital risk-adjusted perioperative mortality should be less than 5% | 8 | Hospital | Outcome |
Based on strict validity criteria (≥90% of expert panel rankings in the 7–9 range). CT = computed tomography; MRI = magnetic resonance imaging.